Loading
札幌臨床検査センター株式会社
Sapporo Clinical Laboratory Inc. is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). Between 18 October 2025 and 18 October 2026, 1 insider published 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (3,419 companies, median 3 filings), a count of 8 filings is above the norm.
No insider has bought Sapporo Clinical Laboratory Inc. shares on the open market in the past twelve months. Between a trade and the moment it shows up on EDINET (Japan FSA), the median delay is 4 days. Until a filing is published, the market cannot know about the trade.
Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
15 of 15 declarations
Sapporo Clinical Laboratory Center Co., Ltd. is a company specializing in medical diagnostic services and clinical testing. It primarily operates in the health and pharmaceutical sector.